ReviewCancer chemotherapy and pharmacology2021
Starting dose selection and dose escalation for oncology small molecule first-in-patient trials: learnings from a survey of FDA-approved drugs.
Rajendar K Mittapalli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it